 |
metronidazole |
|---|---|
| Trade Name | |
| Orphan Indication | Clostridium difficile infection in pediatric patients (0 through 16 years of age) |
| USA Market Approval | USA |
| USA Designation Date | 2016-04-05 00:00:00 |
| Sponsor | Appili Therapeutics, Inc.;1344 Summer Street, Suite 415;Halifax, Nova Scotia |
